Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL845333 | 0.94 | PABPC1 (0.48) | ALDH1A1MEN1KMT2ACYP2C9PABPC1 | |
| SCHEMBL845007 | 0.85 | PABPC1 (0.49) | ALDH1A1MEN1KMT2ACYP2C9PABPC1 | |
| SCHEMBL845131 | 0.85 | PABPC1 (0.49) | ALDH1A1MEN1KMT2ACYP2C9PABPC1 | |
| SCHEMBL845008 | 0.83 | ALDH1A1 (0.54) | NPSR1ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL13272394 | 0.79 | MEN1 (0.47) | ALDH1A1MEN1KMT2ATDP1CYP2C9 | |
| SCHEMBL845697 | 0.79 | ALDH1A1 (0.45) | NPSR1ALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL845295 | 0.79 | KDM4E (0.61) | NPSR1ALDH1A1MEN1KMT2ACYP2C9 | |
| SCHEMBL845251 | 0.78 | PABPC1 (0.50) | ALDH1A1MEN1KMT2ACYP2C9PABPC1 | |
| SCHEMBL845392 | 0.78 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2ACYP2C9PABPC1 | |
| SCHEMBL845403 | 0.78 | GFER (0.46) | ALDH1A1CYP2C9CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |